PL391810A1 - New ziprasidone salts and processes for the preparation thereof - Google Patents

New ziprasidone salts and processes for the preparation thereof

Info

Publication number
PL391810A1
PL391810A1 PL391810A PL39181010A PL391810A1 PL 391810 A1 PL391810 A1 PL 391810A1 PL 391810 A PL391810 A PL 391810A PL 39181010 A PL39181010 A PL 39181010A PL 391810 A1 PL391810 A1 PL 391810A1
Authority
PL
Poland
Prior art keywords
processes
preparation
new
ziprasidone salts
ziprasidone
Prior art date
Application number
PL391810A
Other languages
Polish (pl)
Inventor
Marek Leszek Główka
Waldemar Maniukiewicz
Monika Oracz
Original Assignee
Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna filed Critical Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna
Priority to PL391810A priority Critical patent/PL391810A1/en
Priority to PCT/EP2011/062080 priority patent/WO2012007555A2/en
Publication of PL391810A1 publication Critical patent/PL391810A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
PL391810A 2010-07-14 2010-07-14 New ziprasidone salts and processes for the preparation thereof PL391810A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL391810A PL391810A1 (en) 2010-07-14 2010-07-14 New ziprasidone salts and processes for the preparation thereof
PCT/EP2011/062080 WO2012007555A2 (en) 2010-07-14 2011-07-14 New ziprasidone salts and methods of their formation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL391810A PL391810A1 (en) 2010-07-14 2010-07-14 New ziprasidone salts and processes for the preparation thereof

Publications (1)

Publication Number Publication Date
PL391810A1 true PL391810A1 (en) 2012-01-16

Family

ID=44630161

Family Applications (1)

Application Number Title Priority Date Filing Date
PL391810A PL391810A1 (en) 2010-07-14 2010-07-14 New ziprasidone salts and processes for the preparation thereof

Country Status (2)

Country Link
PL (1) PL391810A1 (en)
WO (1) WO2012007555A2 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX173362B (en) 1987-03-02 1994-02-23 Pfizer PIPERAZINIL HETERO-CYCLIC COMPOUNDS AND PROCEDURE FOR THE PREPARATION
US4831031A (en) 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US5206366A (en) 1992-08-26 1993-04-27 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds
US5312925A (en) 1992-09-01 1994-05-17 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
US5359068A (en) 1993-06-28 1994-10-25 Pfizer Inc. Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one
PT790236E (en) 1996-02-13 2004-04-30 Pfizer 5- (2- (4- (1,2-BENZISOYZAZOL-3-YL) -1-PYRAZAZYL) -ETHYL-6-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONA
BRPI0414082A (en) * 2003-09-02 2006-10-24 Pfizer Prod Inc Sustained-release dosage forms of ziprasidone
CA2552126A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Ziprasidone formulations

Also Published As

Publication number Publication date
WO2012007555A3 (en) 2012-03-15
WO2012007555A2 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
ZA201401833B (en) Ampk-activating heterocyclic compounds and methods for using the same
HK1185558A1 (en) Processes for preparing tubulysins
ZA201300957B (en) 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and use thereof
DK2786756T3 (en) Kombinationsterapi med en topoisomeraseinhibitor
HK1188214A1 (en) Diaminopyrimidine derivatives and processes for the preparation thereof
SI2545048T1 (en) Raltegravir salts and crystalline forms thereof
IL231082A (en) Pyrimido-pyridazinone compounds and use thereof
ZA201208013B (en) " selp-standing comtainer "
GB201004886D0 (en) The Hoppon
GB201009016D0 (en) The SealCase
PL391810A1 (en) New ziprasidone salts and processes for the preparation thereof
SI2590973T1 (en) Solifenacin salts
GB201018845D0 (en) The gauntlag
PL2388095T3 (en) Milling-cutter
PL392328A1 (en) 2 - (Benzyloxycarbonylamine)-6-alkyl izocyanohexanoate and process for the preparation thereof
HU1000498D0 (en) New salts and preparation process thereof
PL392687A1 (en) Process for the biocoal preparation
PL392327A1 (en) 6 - (Benzyloxycarbonylamine)-2-alkyl izocyanohexanoate and process for the preparation thereof
GB201022058D0 (en) The chummy
GB201021054D0 (en) The degravitator
GB201019470D0 (en) The degravitator
GB201016129D0 (en) The gauntlag
GB201014683D0 (en) The seatcase
GB201008831D0 (en) The rambler
GB201013511D0 (en) Salts

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)